Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model-Reference-Cited by-同舟云学术

Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model

Published:2021-02-28 Issue:1 Volume:36 Page:157-170
ISSN:2093-596X
Container-title:Endocrinology and Metabolism
language:en
Short-container-title:Endocrinol Metab

Author:

Kim Jin Hee^ORCID,Lee Gha Young,Maeng Hyo Jin,Kim Hoyoun,Bae Jae Hyun,Kim Kyoung Min,Lim Soo^ORCID

Publisher

Korean Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://e-enm.org/upload/pdf/enm-2020-781.pdf

Reference55 articles.

1. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

2. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?

3. Potential mechanisms promoting restenosis in diabetic patients

4. Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase

5. Glucagon-Like Peptide 1 Recruits Microvasculature and Increases Glucose Use in Muscle via a Nitric Oxide–Dependent Mechanism

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and future perspectives of FGF21 analogues in clinical trials;Trends in Endocrinology & Metabolism;2024-05

2. Exploring the potential mechanism of Simiao Yongan decoction in the treatment of diabetic peripheral vascular disease based on network pharmacology and molecular docking technology;Medicine;2023-12-29

3. Use of FGF21 analogs for the treatment of metabolic disorders: a systematic review and meta-analysis;Archives of Endocrinology and Metabolism;2023-11-13

4. Design and pharmaceutical evaluation of bifunctional fusion protein of FGF21 and GLP-1 in the treatment of nonalcoholic steatohepatitis;European Journal of Pharmacology;2023-08

5. Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs;Antioxidants;2022-05-27